195 related articles for article (PubMed ID: 26426010)
1. Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma.
Fedorko M; Stanik M; Iliev R; Redova-Lojova M; Machackova T; Svoboda M; Pacik D; Dolezel J; Slaby O
Int J Mol Sci; 2015 Sep; 16(10):23382-9. PubMed ID: 26426010
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
Tusong H; Maolakuerban N; Guan J; Rexiati M; Wang WG; Azhati B; Nuerrula Y; Wang YJ
Cancer Biomark; 2017; 18(1):79-85. PubMed ID: 27814278
[TBL] [Abstract][Full Text] [Related]
3. Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma.
Hauser S; Wulfken LM; Holdenrieder S; Moritz R; Ohlmann CH; Jung V; Becker F; Herrmann E; Walgenbach-Brünagel G; von Ruecker A; Müller SC; Ellinger J
Cancer Epidemiol; 2012 Aug; 36(4):391-4. PubMed ID: 22542158
[TBL] [Abstract][Full Text] [Related]
4. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
[TBL] [Abstract][Full Text] [Related]
7. Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma.
Iwamoto H; Kanda Y; Sejima T; Osaki M; Okada F; Takenaka A
Int J Oncol; 2014 Jan; 44(1):53-8. PubMed ID: 24212760
[TBL] [Abstract][Full Text] [Related]
8. Combination of tumor suppressor miR-20b-5p, miR-30a-5p, and miR-196a-5p as a serum diagnostic panel for renal cell carcinoma.
Huang G; Li H; Wang J; Peng X; Liu K; Zhao L; Zhang C; Chen X; Lai Y; Ni L
Pathol Res Pract; 2020 Nov; 216(11):153152. PubMed ID: 32823234
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma.
Zhao A; Li G; Péoc'h M; Genin C; Gigante M
Exp Mol Pathol; 2013 Feb; 94(1):115-20. PubMed ID: 23064048
[TBL] [Abstract][Full Text] [Related]
10. A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
Wang C; Hu J; Lu M; Gu H; Zhou X; Chen X; Zen K; Zhang CY; Zhang T; Ge J; Wang J; Zhang C
Sci Rep; 2015 Jan; 5():7610. PubMed ID: 25556603
[TBL] [Abstract][Full Text] [Related]
11. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma.
Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L
Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891
[TBL] [Abstract][Full Text] [Related]
12. Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma.
Iliev R; Fedorko M; Machackova T; Mlcochova H; Svoboda M; Pacik D; Dolezel J; Stanik M; Slaby O
Anticancer Res; 2016 Dec; 36(12):6419-6423. PubMed ID: 27919963
[TBL] [Abstract][Full Text] [Related]
13. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
Chen Y; Wang X; Zhu X; Shao S
Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
[TBL] [Abstract][Full Text] [Related]
14. Identification of a four-microRNA panel in serum for screening renal cell carcinoma.
Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264
[TBL] [Abstract][Full Text] [Related]
15. The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.
Faragalla H; Youssef YM; Scorilas A; Khalil B; White NM; Mejia-Guerrero S; Khella H; Jewett MA; Evans A; Lichner Z; Bjarnason G; Sugar L; Attalah MI; Yousef GM
J Mol Diagn; 2012 Jul; 14(4):385-92. PubMed ID: 22580180
[TBL] [Abstract][Full Text] [Related]
16. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma.
Sanders I; Holdenrieder S; Walgenbach-Brünagel G; von Ruecker A; Kristiansen G; Müller SC; Ellinger J
Int J Urol; 2012 Nov; 19(11):1017-25. PubMed ID: 22788411
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
Wulfken LM; Moritz R; Ohlmann C; Holdenrieder S; Jung V; Becker F; Herrmann E; Walgenbach-Brünagel G; von Ruecker A; Müller SC; Ellinger J
PLoS One; 2011; 6(9):e25787. PubMed ID: 21984948
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
[TBL] [Abstract][Full Text] [Related]
20. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.
Fedorko M; Juracek J; Stanik M; Svoboda M; Poprach A; Buchler T; Pacik D; Dolezel J; Slaby O
Biochem Med (Zagreb); 2017 Jun; 27(2):411-417. PubMed ID: 28694731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
